CARMIEL, Israel (AP) _ Protalix BioTherapeutics Inc. (PLX) on Wednesday reported a loss of $9.4 million in its first quarter.
The Carmiel, Israel-based company said it had a loss of 6 cents per share.
The drug developer posted revenue of $4.6 million in the period.
The company's shares closed at 40 cents. A year ago, they were trading at 92 cents.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on PLX at https://www.zacks.com/ap/PLX